Back to results
US 2026/0085034 A1Published application
N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof
AssigneeMaze Therapeutics, Inc.
InventorsDavid John MORGANS, JR., Kevin MELLEM, Hannah L. POWERS, Patrick Sang Tae LEE, Walter WON, Christopher Joseph SINZ
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds of formula (I) or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, R1, R2, R3, R4, Y1, Y2, X1, X2, L, and Q1 are as defined elsewhere herein. Also provided herein CN are methods of preparing compounds of formula (I). Also provided herein are methods of inhibiting GYSI and methods of treating a GYS1-mediated disease, disorder, or condition in an individual in need thereof.
Claims83
A compound of formula (I):
- or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein:
- Y1 and Y2 are each CH, or
- one of Y1 and Y2 is N and the other of Y1 and Y2 is CH;
- X1 and X2 are each independently H or halo;
- R3 and R4 are each —CH3, or
- R3 and R4 are taken, together with the atoms to which they are attached, to form cyclopropyl or cyclobutyl;
- either
- (1) L is absent;
- and
- Q1 is:
- (i) C6-20aryl, wherein the C6-20aryl of Q1 is optionally substituted with one or more —OH, —NH2, halo, C1-6alkyl, C1-6alkoxy, C3-10cycloalkyl, 5-20 membered heteroaryl, —NH—C(O)—NH2, —NH—C(O)—NH(C1-6alkyl), —NH—C(O)—C1-6alkyl, —NH—C(O)—C3-10cycloalkyl, —NH—C(O)-(3-15 membered heterocyclyl), —NH—C(═N—CN)—NH2, —NH—S(O)2—C1-6alkyl, —NH(C1-6alkyl), —NH-(3-15 membered heterocyclyl), or —NH-(5-20 membered heteroaryl), wherein
- the 3-15 membered heterocyclyl of the —NH—C(O)-(3-15 membered heterocyclyl) is optionally substituted with one or more —C(O)—C1-6alkyl or C1-6alkyl, wherein the C1-6alkyl is optionally substituted with one or more halo, C1-6alkoxy, or C3-10cycloalkyl, and
- the 3-15 membered heterocyclyl of the —NH-(3-15 membered heterocyclyl) is optionally substituted with one or more oxo or C1-6alkyl, or
- (ii) 3-15 membered heterocyclyl, wherein the 3-15 membered heterocyclyl of Q1 is optionally substituted with one or more oxo, or
- (iii) 5-20 membered heteroaryl, wherein the 5-20 membered heteroaryl of Q1 comprises at least one annular N atom and is optionally substituted with one or more —NH2, halo, C1-6alkyl, or C3-10cycloalkyl;
- or
- (2) L is —CH2—;
- and
- Q1 is C3-10cycloalkyl;
- m is 0 or 1;
- n is 0 or 1;
- R1 is H, halo, —CN, —C(O)—NH2, —C(O)—NH(CN), —C(O)—NH(C1-6alkyl), —NH—C(O)—NH2, or —NH—C(O)—C1-6alkyl, wherein
- the C1-6alkyl of the —C(O)—NH(C1-6alkyl) of R1 is optionally substituted with one or more —C(O)—C1-6alkoxy, and
- the C1-6alkyl of the —NH—C(O)—C1-6alkyl of R1 is optionally substituted with one or more —NH—C(O)—C1-6alkyl or —C(O)—NH2;
- and
- R2 is H, halo, or —OH.
23 more elements
Dependencies are inferred from the claim text.